Prognostic significance of HER-2/neu overexpression in stage I adenocarcinoma of lung

This publication has 11 references indexed in Scilit:

• Serum Level and Tissue Expression of c-erbB-2 Protein in Lung Adenocarcinoma
  Chest, 1995
• Correlation of Intrinsic Chemoresistance of Non-Small-Cell Lung Cancer Cell Lines With HER-2/neu Gene Expression but Not With ras Gene Mutations
  JNCI Journal of the National Cancer Institute, 1993
• Overexpression of the c‐erbB‐2/neu–encoded p185 protein in primary lung cancer
  Molecular Carcinogenesis, 1992
• Mutational Activation of the K-rasOncogene
  New England Journal of Medicine, 1987
• Impact of Early Detection on the Clinical Course of Lung Cancer
  Surgical Clinics of North America, 1987
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
  Science, 1987
• The Product of the Human c- erb B-2 Gene: a 185-Kilodalton Glycoprotein with Tyrosine Kinase Activity
  Science, 1986
• A New International Staging System for Lung Cancer
  Chest, 1986
• Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu Oncogene
  Science, 1985
• Postsurgical Stage I Bronchogenic Carcinoma: Morbid Implications of Recurrent Disease
  The Annals of Thoracic Surgery, 1984